
Isambard AI Accelerates Heart Research
The UK's Isambard AI supercomputer, operational since July 2025 and ranked 11th globally, accelerates genetic heart condition research. This increased computational power reduces experimental timelines for drug developers and research teams, setting a precedent for sustainable high-performance computing in medical discovery.


















